Your browser doesn't support javascript.
loading
Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy-a preclinical study using a syngeneic breast cancer model.
Guzik, Patrycja; Siwowska, Klaudia; Fang, Hsin-Yu; Cohrs, Susan; Bernhardt, Peter; Schibli, Roger; Müller, Cristina.
Afiliação
  • Guzik P; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
  • Siwowska K; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
  • Fang HY; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
  • Cohrs S; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
  • Bernhardt P; Department of Radiation Physics, The Sahlgrenska Academy, University of Gothenburg, SE-413 45, Gothenburg, Sweden.
  • Schibli R; Department of Medical Physics and Medical Bioengineering, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden.
  • Müller C; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
Eur J Nucl Med Mol Imaging ; 48(4): 984-994, 2021 04.
Article em En | MEDLINE | ID: mdl-33078260

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lutécio / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lutécio / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article